Acute Pain Management:
The Transition of Acute Opioid Use to Chronic Opioid Use
A significant concern in the context of today’s “opioid crisis” is the potential for patients treated with opioids for acute post-injury pain to progress to chronic use of opioids. Does this correlate with the transition from acute post-injury pain to chronic post-injury pain? Probably so, for most people. However, concern remains regarding the potential for patients exposed to opioids as part of their post-injury pain management to develop an abusive or addictive relationship with their opioids.
This section explores what is known about this process and is largely based on research evaluating the transition from acute opioid use to chronic opioid use in the post-operative surgery population. Additionally, methods to reduce the transition to chronic opioid use are discussed. Finally, ways to identify individuals at risk for developing opioid addiction (Opioid Use Disorder or OUD) are reviewed, including means to reduce that risk.
See:
See also:
Definitions and Terms Related to Pain
Key to Links:
Grey text – handout
Red text – another page on this website
Blue text – Journal publication
The Transition of Acute Opioid Use to Chronic Opioid Use
To understand the transitioning of acute to chronic opioid use it is important to understand the factors that contribute to the transitioning of acute to chronic pain (See: Acute Pain: Avoiding Transition to Chronic Pain). There is indeed a significant overlap in risks for these two transitions.
The Transition of Acute to Chronic Pain
One of the strongest predictors for the the transitioning of acute to chronic pain following surgery acute injury is the presence of pain prior to the injury, including back pain, neck pain, arthritis and migraine headaches. This is especially true when the pain is accompanied by central sensitization, a condition associated with many chronic pain syndromes that is characterized by changes in nerves and nerve pathways in the brain and spinal cord. This sensitization results in the magnification of pain experiences where what should be a mild pain is experienced as moderate or severe pain or where sensations that are not normally painful become painful.
Other strong risk factors that predict transitioning from acute to chronic pain include psychiatric disorders such as depression, bipolar disorder, post traumatic stress disorder (PTSD) and anxiety. Additional risk factors are tobacco, alcohol and other substance abuse disorders.
Transitioning from Acute to Chronic Opioid Use After Surgery
Most of the studies that have evaluated the transition from acute to chronic opioid use have done so in the framework of post-surgical pain. Studies have been published that evaluate the incidence and risk factors for persistent opioid use after surgery. In 2017 a study evaluated nationwide insurance claims from 2013 to 2014 involving US adults aged 18 to 64 years who were without opioid use in the year prior to surgery (ie, no opioid prescription prescriptions filled from 12 months to 1 month prior to the procedure).
In this study group of 36,177 patients, the incidence of persistent opioid use for more than 90 days and up to 180 days after both minor and major surgical procedures was identified. Minor surgeries included: varicose vein removal, laparoscopic gall bladder removal, laparoscopic appendectomy, hemorrhoidectomy, thyroidectomy, transurethral prostate surgery, parathyroidectomy, and carpal tunnel surgery. Major surgical procedures included: ventral incisional hernia repair, colectomy, reflux surgery, bariatric surgery, and hysterectomy. The study identified 29,068 (80.3%) patients who had minor surgical procedures and 7109 (19.7%) who had major procedures.
The rates of new persistent opioid use were unexpectedly similar between both the minor and major surgical procedure groups, ranging from 5.9% to 6.5%, indicating that some patients likely continue opioids for reasons other than solely the intensity of surgical pain. By comparison, as would be expected, the incidence in the non-operative control group was less: only 0.4%. Of note, these results are also comparable with the 5% incidence of new long-term opioids use after the first opioid exposure based on data from the Oregon prescription drug monitoring program, which includes non-surgery related opioid prescriptions.
Another 2017 study of 1,294,247 patients published by the Center for Disease Control (CDC) evaluated the characteristics of initial opioid prescriptions and the likelihood of long-term opioid use in the United States from 2006–2015. This study found that 33,548 (2.6%) of patients continued opioid therapy for ≥1 year. This group was more likely to be older, female, or to have a pain diagnosis before opioid initiation, to have been initiated on higher doses of opioids and were publicly or self-insured.
Among patients prescribed opioids, the probability of continued opioid use at 1 year was 6.0% and at 3 years was 2.9%. The probability of continued opioid use increased to 13.5% at one year for patients whose first time period of use was for ≥8 days and to 29.9% when the first time period of use was for ≥31 days. The risk for persistent opioid use at one year doubled when a second prescription was provided or when 700 morphine milligram equivalents (ME) or more as a cumulative dose was prescribed.
The highest probabilities of continued opioid use at 1 and 3 years were observed among patients who initiated treatment with a long-acting opioid (27.3% at 1 year; 20.5% at 3 years), followed by those whose initial treatment was with tramadol (13.7% at 1 year; 6.8% at 3 years) or a Schedule II short-acting opioid other than hydrocodone or oxycodone (8.9% at 1 year; 5.3% at 3 years). The probabilities of continued opioid use at 1 and 3 years for patients starting on hydrocodone short-acting (5.1% at 1 year; 2.4% at 3 years), oxycodone short-acting (4.7% at 1 year; 2.3% at 3 years), or Schedule III–IV (5.0% at 1 year; 2.2% at 3 years).
The finding that patients initiated with tramadol had the next highest probability of long-term use was unexpected. Because of tramadol’s minimal affinity for the μ-opioid receptor it is considered a relatively safe opioid with lower abuse potential. Among patients initiated with tramadol, >64% of patients who continued opioid use beyond 1 year were still on tramadol. Given that physicians and the general public’s belief that tramadol is safer and less addicitve that other opoioids, it suggests that tramadol is prescribed intentionally for chronic pain management.
Unfortunately, other opioids such as buprenorphine, tapentadol and levorphanol that offer greater benefit for nerve pain were not reported on. Because the chronification of pain is greater in those with nerve pain, the use of opioids that may have more favorable impact on neuropathic pain might be preferred. Opioids thought to be more effective for neuropathic pain include buprenorphine (Belbuca and Butrans), tramadol (Ultram), tapentadol (Nucynta), methadone and possibly fentanyl (Duragesic). Unfortunately, no research to date has explored this theory to evalute its merit.
It is important to remember that these statistics represent associations and do not establish cause and effect. In the 2017 study above, information on pain intensity or pain duration were not available and the cause of pain, which might influence the duration of opioid use, was not considered in the analysis.
The CDC concluded that the transition from acute to long-term opioid use can begin quickly: the chances of chronic use begin to increase after the third day and rise rapidly thereafter. Based on these results, CDC guidelines recommend that treatment of acute pain with opioids should be for the shortest duration possible. Prescribing <7 days (ideally ≤3 days) of medication when initiating opioids may reduce the chances of unintentional chronic opioid use. When initiating opioids, the CDC recommends caution when prescribing >1 week of opioids or when providing a refill or a second opioid prescription because these actions approximately double the chances of opioid use 1 year later.
As addressed above and emphasized throughout this web site, pain perception is complex, with multiple variables that contribute to the severity and persistence of pain and, most importantly, the degree to which people suffer and/or are compromised by their pain. It requires diligence on the part of pain patients and their clinicians to take steps to reduce the incidence of preventable chronification of post-injury pain and opioid use.
Management Factors Related to Transition to Chronic Opioid Use
The most important variable in the transition of acute to chronic use of opioids is the effectiveness of pain management in the acute post-injury or post-surgical time period. The earlier acute post-injury or post-surgical pain is well controlled, the less likely the pain will become chronic (>3 months duration) and a shorter duration of opioid use would be expected. For more information in acute pain management and the transitioning of acute to chronic pain, see Acute Pain Transition to Chronic Pain.
It has been established that the transition from acute to chronic pain involves changes in the nervous system including the development of neuropathic pain (See: Neuropathic Pain) and a process of peripheral and central sensitization. Treatment directed at reducing central sensitizaton is an important component of managing acute pain in an effort to reduce the transition to chronic pain and therefore is expected to reduce the chronification of opioid use. (See: Central Sensitization).
It may follow that which opioid(s) are used in the management of acute pain might influence the chronification of opioid use. As such the use of opioids that may have more favorable impact on neuropathic pain would be preferred. Opioids thought to be more effective for neuropathic pain include buprenorphine (Belbuca and Butrans), tramadol (Ultram), tapentadol (Nucynta), methadone and possibly fentanyl (Duragesic). Unfortunately, no research to date has explored this theory to evalute its merit.
References:
Preventing Pain Related to Surgery – Overviews
- perioperative-pain-management- 2007 pubmed-ncbi
- Pharmacotherapy for the prevention of chronic pain after surgery in adults (Review) – 2013
- optimizing-pain-management-to-facilitate-enhanced-recovery-after-surgery-pathways 2015 -pubmed-ncbi
- development-of-a-management-algorithm-for-post-operative-pain-mapp-after-total-knee-and-total-hip-replacement-2014
- Post-operative Opioid-Induced Hyperalgesia – ICM Case Summaries – 2016
- The Complexity Model – A Novel Approach to Improve Chronic Pain Care – 2014
- Postoperative_pain_from_mechanisms_to_treatment.
- Mechanisms of acute and chronic pain after surgery: update from findings in experimental animal models. – PubMed – NCBI – 2018
- Short-term pre- and post-operative stress prolongs incision-induced pain hypersensitivity without changing basal pain perception – 2015
- Age and preoperative pain are major confounders for sex differences in postoperative pain outcome – A prospective database analysis – 2017
- Optimizing pain management to facilitate Enhanced Recovery After Surgery pathways. – PubMed – NCBI – 2015
- Reward Circuitry Plasticity in Pain Perception and Modulation – 2017
- Surgically-Induced Neuropathic Pain (SNPP) – Understanding the Perioperative Process – 2013
- Preventing Chronic Pain following Acute Pain – Risk Factors, Preventive Strategies, and their Efficacy – 2011
- Regular physical activity prevents development of chronic pain and activation of central neurons – 2013
- Regional anaesthesia to prevent chronic pain after surgery – a Cochrane systematic review and meta-analysis – 2013
- Pharmacotherapy for the prevention of chronic pain after surgery in adults – 2017
- A systematic review of therapeutic interventions to reduce acute and chronic post-surgical pain after amputation, thoracotomy or mastectomy. – 2015
- Analysis of perioperative pain management in vascular surgery indicates that practice does not adhere with guidelines – a retrospective cross-sectional study – 2017
- Efficacy and safety of multimodal analgesic techniques for preventing chronic postsurgery pain under different surgical categories – a meta-analysis – 2017
- Postoperative pain—from mechanisms to treatment – 2017
- Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children – 2018
- Chronic postsurgical pain – current evidence for prevention and management – 2018
- Preventive analgesia and novel strategies for the prevention of chronic post-surgical pain. – (2015)
- Poorly controlled postoperative pain – prevalence, consequences, and prevention – 2017
- Designing the ideal perioperative pain management plan starts with multimodal analgesia – 2018
- Special indications for Opioid Free Anaesthesia and Analgesia, patient and procedure related: Including obesity, sleep apnoea, chronic obstructive … – PubMed – NCBI – 2017
- Chronic pain patient and anaesthesia – 2019
- New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults – 2017
- Multimodal Analgesia, Current Concepts, and Acute Pain Considerations. – PubMed – NCBI -2017
- Recent Advances in Postoperative Pain Management – 2010
- Effect of perioperative systemic alpha2-agonists on postoperative morphine consumption and pain intensity – systematic review of randomized controlled trials- 2011
- Cannabinoids for Postoperative Pain – 2007
- Educating Patients Regarding Pain Management and Safe Opioid Use After Surgery – 2020
Transition of Acute Opioid Use to Chronic Opioid Use
- Preventing Chronic Pain following Acute Pain – Risk Factors, Preventive Strategies, and their Efficacy – 2011
- Post-operative Opioid-Induced Hyperalgesia – ICM Case Summaries – 2016
- FACTORS INFLUENCING LONG-TERM OPIOID USE AMONG OPIOID NAÏVE PATIENTS – AN EXAMINATION OF INITIAL PRESCRIPTION CHARACTERISTICS AND PAIN ETIOLOGIES – 2017
- New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults – 2017
- Educating Patients Regarding Pain Management and Safe Opioid Use After Surgery – 2020
Preventing Pain Related to Surgery – Phantom Limb Pain
- Strategies for prevention of lower limb post-amputation pain: A clinical narrative review – 2018
- Optimized perioperative analgesia reduces chronic phantom limb pain intensity, prevalence, and frequency: a prospective, randomized, clinical trial. – PubMed – NCBI – 2011
- Chronic post-amputation pain – peri-operative management – Review 0- 2017
Preventing Pain Related to Surgery – Enhanced Recovery After Surgery (ERAS)
- Enhanced Recovery After Surgery: A Review. – PubMed – NCBI – 2017
- Pain management within an enhanced recovery program after thoracic surgery – 2018
- Optimizing pain management to facilitate Enhanced Recovery After Surgery pathways. – PubMed – NCBI – 2015
Preventing Pain Related to Surgery – Neuroinflammation, Glial Cells & Mast Cells
- Involvement of mast cells in a mouse model of postoperative pain. – PubMed – NCBI – 2011
- An Inflammation-Centric View of Neurological Disease – Beyond the Neuron – 2018
- Rescue of Noradrenergic System as a Novel Pharmacological Strategy in the Treatment of Chronic Pain – Focus on Microglia Activation – 2019
Preventing Pain Related to Surgery – Resolving Inflammation
- Vagus nerve controls resolution and pro-resolving mediators of inflammation – 2014
- The Resolution Code of Acute Inflammation – Novel Pro-Resolving Lipid Mediators in Resolution – 2015
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. – PubMed – NCBI – 2018
- Resolvins and protectins – mediating solutions to inflammation – 2009
- Resolvins and inflammatory pain – 2011
- Resolution of inflammation – an integrated view – 2013
- Protectins and maresins – New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome – 2014
- Proresolving lipid mediators and mechanisms in the resolution of acute inflammation – 2014
- Novel Pro-Resolving Lipid Mediators in Inflammation Are Leads for Resolution Physiology – 2014
- Novel Anti-Inflammatory — Pro-Resolving Mediators and Their Receptors – 2011
- Lipid Mediators in the Resolution of Inflammation – 2015
- PPARγ activation ameliorates postoperative cognitive decline probably through suppressing hippocampal neuroinflammation in aged mice. – PubMed – NCBI – 2017
- Postoperative cognitive dysfunction in the aged: the collision of neuroinflammaging with perioperative neuroinflammation. – PubMed – NCBI – 2018
- The Role of Neuroinflammation in Postoperative Cognitive Dysfunction – Moving From Hypothesis to Treatment – 2018
- Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms – 2017
- Structural Elucidation and Physiologic Functions of Specialized Pro-Resolving Mediators and Their Receptors – 2017
- LPS is a Switch for Inflammation in the Gut and Beyond
- Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation – a methodological validation – 2018
- The Protectin Family of Specialized Pro-resolving Mediators – Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes – 2018
- Protectins and Maresins – New Pro-Resolving Families of Mediators in Acute Inflammation and Resolution Bioactive Metabolome – 2014
- Functional Metabolomics Reveals Novel Active Products in the DHA Metabolome – 2012
Preventing Pain Related to Surgery – Alpha-2 Agonists
Preventing Pain Related to Surgery – Buprenorphine
- Role of buprenorphine in acute postoperative pain – 2016
- Efficacy and Safety of Transdermal Buprenorphine versus Oral Tramadol:Acetaminophen in Patients with Persistent Postoperative Pain after Spinal Surgery – 2017
- Low-dose buprenorphine infusion to prevent postoperative hyperalgesia in patients undergoing major lung surgery and remifentanil infusion a double-blind, randomized, active-controlled trial – 2017
Preventing Pain Related to Surgery – Diet
Preventing Pain Related to Surgery – Genetics
- genotyping-test-with-clinical-factors-better-management-of-acute-postoperative-pain-2015
- the-impact-of-genetic-variation-on-sensitivity-to-opioid-analgesics-in-patients-with-postoperative-pain-a-systematic-review-and-meta-analysis-2015
- Chronic postsurgical pain – is there a possible genetic link? – 2017
Preventing Pain Related to Surgery – Epigenetics
- Epigenetic-regulation-of-spinal-cord-gene-expression-controls-opioid-induced-hyperalgesia-2014
- Epigenetic-regulation-of-opioid-induced-hyperalgesia-dependence-and-tolerance-in-mice-2013
- Epigenetic-regulation-of-persistent-pain-2015
- Chronic-opioid-use-is-associated-with-increased-dna-methylation-correlating-with-increased-clinical-pain-pubmed-ncbi
- Could targeting epigenetic processes relieve chronic pain states? – PubMed – NCBI
- Epigenetic-mechanisms-of-chronic-pain-2015
- Telomeres and epigenetics – Potential relevance to chronic pain – 2012
- Epigenetics of chronic pain after thoracic surgery. – PubMed – NCBI
- Epigenetics-in-the-perioperative-period-2015
Preventing Pain Related to Surgery – Gabapentin & Pregabalin
- Do surgical patients benefit from perioperative gabapentin:pregabalin? A systematic review of efficacy and safety. – PubMed – NCBI
- Perioperative administration of gabapentin 1,200 mg day−1 and pregabalin 300 mg day−1 for pain following lumbar laminectomy and discectomy – 2011
- Preemptive use of gabapentin in abdominal hysterectomy: a systematic review and meta-analysis. – PubMed – NCBI
- The Effect of Gabapentin on Acute Postoperative Pain in Patients Undergoing Total Knee Arthroplasty – 2016
- The prevention of chronic postsurgical pain using gabapentin and pregabalin: a combined systematic review and meta-analysis. – PubMed – NCBI
- The use of gabapentin in the management of postoperative pain after total hip arthroplasty – 2016
- The use of gabapentin in the management of postoperative pain after total knee arthroplasty – 2016
- Use of gabapentin for perioperative pain control – A meta-analysis – 2007
- The efficacy of gabapentin:pregabalin in improving pain after tonsillectomy: A meta-analysis. – PubMed – NCBI
- Effects of gabapentin on postoperative pain, nausea and vomiting after abdominal hysterectomy: a double blind randomized clinical trial. – PubMed – NCBI
- Gabapentin and postoperative pain – a systematic review of randomized controlled trials 2006 – PubMed Health
- Preoperative Preemptive Drug Administration for Acute Postoperative Pain – A Systematic Review And Meta-Analysis – 2016
- the-effects-of-preoperative-oral-pregabalin-and-perioperative-intravenous-lidocaine-infusion-on-postoperative-morphine-requirement-in-patients-undergoing-laparatomy-2015
- perioperative-pain-management- 2007 pubmed-ncbi
- optimizing-pain-management-to-facilitate-enhanced-recovery-after-surgery-pathways 2015 -pubmed-ncbi
- Treatment_of_Neuropathic_Pain_The_Role_of_Unique_Opioid_Agents_-_2016
- The Anti-Allodynic Gabapentinoids – Myths, Paradoxes, and Acute Effects – 2016
- Gabapentinoids as a Part of Multi-modal Drug Regime for Pain Relief following Laproscopic Cholecystectomy: A Randomized Study – 2017
- Effects of pregabalin and gabapentin on postoperative pain and opioid consumption after laparoscopic cholecystectomy – 2017
- Do surgical patients benefit from perioperative gabapentin:pregabalin? A systematic review of efficacy and safety. – PubMed – NCBI
- Impact of pregabalin on acute and persistent postoperative pain: a systematic review and meta-analysis. – PubMed – NCBI
- Effects of pregabalin and gabapentin on postoperative pain and opioid consumption after laparoscopic cholecystectomy – 2017
- Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort – 2018
Preventing Pain Related to Surgery – Ketamine & NMDA Antagonists
- Role of Ketamine in Acute Postoperative Pain Management – A Narrative Review – 2015
- Perioperative ketamine for acute postoperative pain. – PubMed – NCBI
- Ketamine decreases postoperative pain scores in patients taking opioids for chronic pain: results of a prospective, randomized, double-blind study. – PubMed – NCBI
- Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery. – PubMed – NCBI
- Ketamine as an Adjunct to Postoperative Pain Management in Opioid Tolerant Patients After Spinal Fusions – A Prospective Randomized Trial – 2007
- The efficacy of N-methyl-D-aspartate receptor antagonists on improving the postoperative pain intensity and satisfaction after remifentanil-based a… – PubMed – NCBI
- The clinical role of NMDA receptor antagonists for the treatment of postoperative pain. – PubMed – NCBI
- Ketamine – an old drug revitalized in pain medicine – 2017
- Effect of ketamine combined with magnesium sulfate in neuropathic pain patients (KETAPAIN) – study protocol for a randomized controlled trial – 2017
- A systematic review and meta-analysis of ketamine for the prevention of persistent post-surgical pain. – PubMed – NCBI – 2014
- Ketamine for pain – 2017
- Ketamine for pain management – 2018
- Butorphanol and Ketamine Combined in Infusion Solutions for Patient-Controlled Analgesia Administration – A Long-Term Stability Study – 2015
- Multimodal Analgesia, Current Concepts, and Acute Pain Considerations. – PubMed – NCBI -2017
Preventing Pain Related to Surgery – Magnesium
- Perioperative systemic magnesium to minimize postoperative pain: a meta-analysis of randomized controlled trials. – PubMed – NCBI
- Peri-operative intravenous administration of magnesium sulphate and postoperative pain – a meta-analysis – 2013
- Effect of magnesium sulfate on morphine activity retention to control pain after herniorrhaphy. – PubMed – NCBI
- Effect of ketamine combined with magnesium sulfate in neuropathic pain patients (KETAPAIN) – study protocol for a randomized controlled trial – 2017
Preventing Pain Related to Surgery – NSAIDs
See: NSAIDs
- Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity? – PubMed – NCBI – 2013
- Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of ‘sulfa’ allergy. – PubMed – NCBI 2001
Preventing Pain Related to Surgery – Nefopam
- nefopam-after-total-hip-arthroplasty-role-in-multimodal-analgesia-pubmed-ncbi
- nefopam-analgesia-and-its-role-in-multimodal-analgesia-a-review-of-preclinical-and-clinical-studies-pubmed-ncbi
- preventive-analgesic-efficacy-of-nefopam-in-acute-and-chronic-pain-after-breast-cancer-surgery-2016
- neuronal-sensitization-and-its-behavioral-correlates-in-a-rat-model-of-neuropathy-are-prevented-by-a-cyclic-analog-of-orphenadrine-pubmed-ncbi
Preventing Pain Related to Surgery – Tapentadol (Nucynta)
Preventing Pain Related to Surgery – Vitamin C
Chronic Regional Pain Syndrome (CRPS)/Reflex Sympathetic Dystrophy (RSD)
- Efficacy of vitamin C in preventing complex regional pain syndrome after wrist fracture – A systematic review and meta-analysis – 2017
- [Vitamin C and prevention of reflex sympathetic dystrophy following surgical management of distal radius fractures]. – PubMed – NCBI
- Complex regional pain syndrome – recent updates – 2013
- Give vitamin C to avert lingering pain after fracture – 2008
- Effect of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures – a randomised trial – 1999
- Effect of vitamin C on prevention of complex regional pain syndrome type I in foot and ankle surgery. – PubMed – NCBI – 2009
Preventing Pain Related to Surgery – Vitamin C
Lumbar Surgery
Preventing Pain Related to Surgery – Vitamin D
- The Preoperative Supplementation With Vitamin D Attenuated Pain Intensity and Reduced the Level of Pro-inflammatory Markers in Patients After Posterior Lumbar Interbody Fusion – 2019
- Vitamin D and Its Potential Interplay With Pain Signaling Pathways – 2020
- Vitamin D for the treatment of chronic painful conditions in adults – 2014
- Vitamin D in Pain Management – 2017
- Is there a role for vitamin D in the treatment of chronic pain? – 2017
- Vitamin D Deficiency and Pain – Clinical Evidence of Low Levels of Vitamin D and Supplementation in Chronic Pain States- 2015
Opioids – Transitioning from Short Term to Long Term Use
- How acute pain leads to chronic opioid use – 2018
- Characteristics of initial prescription episodes and likelihood of long-term opioid use – United States, 2006-2015
- New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults – 2017
- FACTORS INFLUENCING LONG-TERM OPIOID USE AMONG OPIOID NAÏVE PATIENTS – AN EXAMINATION OF INITIAL PRESCRIPTION CHARACTERISTICS AND PAIN ETIOLOGIES – 2017
- Acute Pain Is Associated With Chronic Opioid Use After Total Knee Arthroplasty – 2018
Tramadol
- Chronic use of tramadol after acute pain episode cohort study – 2019
- A Systematic Review of Laboratory Evidence for the Abuse Potential of Tramadol in Humans – 2019
- Clinical characteristics distinguishing tramadol-using adolescents from other substance-using adolescents in an out-patient treatment setting – 2020
- Use of tramadol and other analgesics following media attention and risk minimization actions from regulators – a Danish nationwide drug utilization study – 2021
- Abuse Liability and Reinforcing Efficacy of Oral Tramadol in Humans – 2013
- FACTORS INFLUENCING LONG-TERM OPIOID USE AMONG OPIOID NAÏVE PATIENTS – AN EXAMINATION OF INITIAL PRESCRIPTION CHARACTERISTICS AND PAIN ETIOLOGIES – 2017
- Acute Pain Is Associated With Chronic Opioid Use After Total Knee Arthroplasty – 2018
- Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal – A two-phase randomized controlled trial* – 2013
Emphasis on Education
Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.
For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.
Please note also, that many of the benefits for medications described on this web site include “off-label” use for a medication. Off-label prescribing refers to the use of medication for a condition not named in its FDA approval. Physicians are free to prescribe any medication they want, as long as there is some evidence for usefulness. And remember that the lack of an FDA indication does not necessarily mean lack of efficacy—it sometimes means that no drug company has deemed the investment in clinical trials worth the eventual pay off.
Should you wish more information regarding any of the subjects listed – or not listed – here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.
For more information, please contact Accurate Clinic.
Supplements recommended by Dr. Ehlenberger may be purchased commercially online or at Accurate Clinic.
Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.
Accurate Supplement Prices